Working… Menu

Efficacy & Safety of ODSH (2-0, 3-0 Desulfated Heparin) in Patients With Metastatic Pancreatic Cancer Treated With Gemcitabine & Abraxane (PGPC1)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01461915
Recruitment Status : Completed
First Posted : October 28, 2011
Last Update Posted : August 29, 2016
Translational Drug Development
Information provided by (Responsible Party):
Cantex Pharmaceuticals